Company intelligence
GFE Blut
Pioneers in NAT blood screening
About GFE Blut
GFE was founded in 2005 by blood donation services of the German Red Cross and quickly developed into a leading company for virus detection using nucleic acid amplification technology (NAT) in blood donations in Germany. The founders of GFE are recognized experts in blood donation diagnostics and were heavily involved in cutting-edge research. They were instrumental in developing the techniques and procedures that led to the establishment of NAT testing as a routine method for blood donor screening in Germany in the 1990s. Today, GFE offers CE-IVD labeled NAT testing solutions for all transfusion-relevant viruses, featuring state-of-the-art technologies, such as multi-dye and multi-target assays, and excellent sensitivity, specificity and robustness to target mutations.
Verified activity
Signals from GFE Blut
2 published signals
Presence & Recognition
GFE Blut is attending the German Congress for Transfusion Medicine and Immunohematology (DGTI) from September 23 to 25 at booth 20 in Seegene Germany GmbH's booth.
Reported by GFE Blut
People
GFE Blut is hiring a new MTA/BTA/CTA or Biologielaborant for production of molecular diagnostic tests in Frankfurt am Main, Hesse.
Reported by GFE Blut